ARLINGTON, VA (April 19, 2017) — The National Osteoporosis Foundation (NOF), the nation’s leading healthcare organization dedicated to bone health, has named Catrell Harris as its new Director of Science and Education. Harris is a seasoned nonprofit industry veteran with in-depth health experience and a track record of delivering profitable, innovative solutions to business challenges…. Read more »
News
NOF Partners with Farmacopea, Inc. to Conduct Health Education Outreach to Hispanic Audiences in the United States »
ARLINGTON, VA (April 5, 2017) — The National Osteoporosis Foundation (NOF), the nation’s leading healthcare organization dedicated to bone health, announced today a new partnership with Farmacopea, Inc., an independent, minority-owned and women-owned agency that consults with clients on healthcare advertising and communications to target Spanish-speaking patients, caregivers and healthcare professionals. Together, NOF and Farmacopea… Read more »
Osteopenia: Causes, treatments, and prevention »
As a person ages, bone density can naturally decrease. Osteopenia is characterized by extremely low bone density, regardless of age. Read the full article about osteopenia vs. osteoporosis here: http://www.medicalnewstoday.com/articles/318321.php.
Osteoporosis Care is Under Siege: How You Can Help »
Fractures related to osteoporosis threaten the health and independence of older Americans. And fractures are common: more than 2 million fractures happen each year due to osteoporosis. The statistics are staggering and unnecessary. A DXA (Dual-energy X-ray absorptiometry) bone density test is a non-invasive, simple, yet top-quality test for screening and diagnosing patients that may… Read more »
How to Beat Your Genes When it Comes to Cancer, Diabetes, and More »
You can’t hit the reset button when it comes to your family health history, but you can lower the odds that you’ll suffer a similar fate. Learn how to beat your genes when it comes to cancer, diabetes, osteoporosis, and more: http://www.womansday.com/health-fitness/womens-health/g3068/how-to-beat-your-genes/
Health Buzz: Meredith Vieira: ‘There’s No Excuse for Not Thinking About Bone Health’ »
Meredith Vieira, the popular journalist and talk-show host says “There’s no excuse for not knowing about bone health and being proactive with your doctor.” Vieira, 63, who’s teamed up with bonenews.com, is opening up about her connection to osteoporosis, which affects about 10 million Americans over age 50, and the link between fractures and postmenopausal… Read more »
The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay »
Washington, DC (June 13, 2017) – The National Osteoporosis Foundation (NOF), today issued the following statement in response to the Senate HELP hearing “The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay” “During today’s hearing, several Senators raised the idea of allowing for the government to set prices in the… Read more »
Osteoporosis: ACP update treatment guidelines for preventing bone fractures »
To reduce the risk of hip and vertebral fractures in women with osteoporosis, physicians should treat them with the bisphosphonates risedronate, alendronate, or zoledronic acid, or alternatively with the biologic agent denosumab. This strong recommendation appears in revised guidelines from the American College of Physicians (ACP) for the prevention of fractures in men and women… Read more »
NOF Response to the Newly Published “Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians” (ACP) »
On Monday, May 8th, the American College of Physicians (ACP) released its updated guidelines for treatment of men and women with low bone density or osteoporosis. The National Osteoporosis Foundation (NOF) applauds the ACP for recognizing the need to update its previous guidelines from 2008 and emphasizing the importance of treatment for osteoporosis and the… Read more »
FDA Approves Radius Health’s TYMLOS™ (abaloparatide) »
Apr 28, 2017 FDA Approves Radius Health’s TYMLOS™ (abaloparatide), a Bone Building Agent for the Treatment of Postmenopausal Women with Osteoporosis at High Risk for Fracture TYMLOS is the first new anabolic (bone building) agent for postmenopausal women with osteoporosis in the United States in nearly 15 years US Commercial Launch in May Approval Based… Read more »